BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS




Industry
Biotechnology






 Company News
Amarantus BioSciences, Inc. Opens Investigational New Drug (IND) Application With The U.S. FDA Allowing The Start Of A Phase 2b Program Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 3/26/2015 10:49:41 AM
Amarantus BioSciences, Inc. To Present At The Neurotech Investing And Partnering Conference On Tuesday, April 7, 2015 3/23/2015 9:58:29 AM
Amarantus BioSciences, Inc. To Present Positive Alzheimer's Disease Biomarker Data On The Lympro Test At The 2/23/2015 8:01:00 AM
Amarantus BioSciences, Inc. Announces First Alzheimer's Biomarker Services Collaboration For Lympro Test With Anavex Life Sciences Corp. (AVXL) 2/18/2015 8:23:07 AM
Amarantus BioSciences, Inc. Announces Publication In BRAIN Of Eltoprazine Phase 2a Clinical Study For Treating Parkinson's Disease Levodopa-Induced Dyskinesia 2/10/2015 7:34:51 AM
Amarantus BioSciences, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 10, 2015 2/3/2015 8:38:21 AM
Amarantus BioSciences, Inc. Forms Alzheimer's Disease Diagnostics Scientific Advisory Board 1/22/2015 7:42:18 AM
Amarantus BioSciences, Inc. Announces Exclusive Option Agreement With Georgetown University To License Patent Rights For Blood Based Biomarkers For Alzheimer's Disease 1/15/2015 7:02:15 AM
Amarantus BioSciences, Inc. Announces Positive Data From 140 Subject LP-002 Clinical Study Of Lympro Test® Confirming Statistically Significant Markers For Alzheimer's 1/15/2015 7:00:54 AM
Amarantus BioSciences, Inc. To Present At Noble Financial Capital Markets' Eleventh Annual Investor Conference 1/13/2015 6:56:22 AM
12345678910...